NEW HAVEN, Conn.–(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced an
operational plan to re-align the global organization with its refocused
corporate strategy. The plan is expected to deliver approximately $270
million in GAAP and approximately $250 million in non-GAAP pre-tax
savings annually by 2019. The restructuring will reduce the Companys
global workforce by approximately 20%. The resulting savings will allow
Alexion to prioritize investments to advance growth opportunities,
optimize capabilities across the organization, and position Alexion to
deliver on its financial ambitions, including growing GAAP operating
margin to 37%…
Read the full article at: http://www.businesswire.com/news/home/20170912005678/en/Alexion-Announces-Restructuring-Advance-Corporate-Strategy